Clinical trial
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV)…
NCT00000995 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000995 |
|---|---|
| Title | A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection |
| Official title | Phase I Studies of the Combination of AZT and DHPG (Ganciclovir) in Patients With AIDS and Cytomegalovirus Infection |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections, HIV Infections |
| Intervention type | Drug |
| Interventions | Zidovudine, Ganciclovir |
| Enrollment | 60 |
| Completion | Feb 1, 1990 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 4, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: